Literature DB >> 11760736

Is timing of death from tumor recurrence predictable after curative resection for gastric cancer?

E Otsuji1, S Kobayashi, K Okamoto, A Hagiwara, H Yamagishi.   

Abstract

It is still difficult to predict whether cancer in patients who undergo curative gastrectomy for gastric cancer will recur and when they will die of recurrence. This study clarified predictive factors related to timing of death from tumor recurrence. A multivariate analysis was used to assess the dependence of death on postoperative tumor recurrence and were the dependence of the timing of death on tumor recurrence. Patients were divided into two groups according to the timing of death: those who died of tumor recurrence less than 2 years after surgery and those who died more than 2 years after surgery. Depth of cancer invasion, regional lymph node metastasis, and tumor size were independently correlated with tumor recurrence after curative gastrectomy. Onlv the depth of cancer invasion independently correlated with the timing of death due to tumor recurrence. It might be possible to predict the timing of death from tumor recurrence by the depth of cancer invasion into the gastric wall.

Entities:  

Mesh:

Year:  2001        PMID: 11760736     DOI: 10.1007/s00268-001-0143-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  6 in total

1.  Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion.

Authors:  Eigo Otsuji; Yoshiaki Kuriu; Daisuke Ichikawa; Kazuma Okamoto; Toshiya Ochiai; Akeo Hagiwara; Hisakazu Yamagishi
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

2.  Short-term and long-term risk factors in gastric cancer.

Authors:  Giuseppe Verlato; Daniele Marrelli; Simone Accordini; Maria Bencivenga; Alberto Di Leo; Alberto Marchet; Roberto Petrioli; Giacomo Zoppini; Michele Muggeo; Franco Roviello; Giovanni de Manzoni
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

3.  The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data.

Authors:  Bin-Bin Xu; Jun Lu; Zhi-Fang Zheng; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Chao-Hui Zheng; Chang-Ming Huang; Ping Li
Journal:  Gastric Cancer       Date:  2019-02-09       Impact factor: 7.701

4.  Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.

Authors:  Mitsuyoshi Okazaki; Sachio Fushida; Shinichi Harada; Tomoya Tsukada; Jun Kinoshita; Katsunobu Oyama; Tomoharu Miyashita; Itasu Ninomiya; Tetsuo Ohta
Journal:  BMC Cancer       Date:  2017-01-05       Impact factor: 4.430

5.  Detection and Characterization of Metastatic Cancer Cells in the Mesogastrium of Gastric Cancer Patients.

Authors:  Daxing Xie; Liang Liu; Hasan Osaiweran; Chaoran Yu; Fang Sheng; Chun Gao; Junbo Hu; Jianping Gong
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

6.  Clinicopathological Characteristics and Prognosis of Upper Gastric Cancer Patients in China: A 32-Year Single-Center Retrospective Clinical Study.

Authors:  Yingbo Gong; Pengliang Wang; Zhi Zhu; Junyan Zhang; Jinyu Huang; Huimian Xu
Journal:  Gastroenterol Res Pract       Date:  2019-12-01       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.